Item 8.01. Other Events.
On July 5, 2022, Allena Pharmaceuticals, Inc. issued a press release announcing
that it has rescheduled its special meeting, which was scheduled for July 5,
2022, to, among other things, consider and vote on a proposed amendment to its
amended and restated certificate of incorporation, as amended, in order to
effect a reverse stock split of its issued and outstanding common stock. The
date of the rescheduled special meeting, and the new record date for determining
the Allena stockholders entitled to vote thereat, will be determined in the near
future, and will be will be included in supplemental proxy materials to be filed
with the SEC and distributed to stockholders promptly after the new record date.
A copy of the Company's press release is attached hereto as Exhibit 99.1 and
incorporated by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number Description
99.1 Press Release dated July 5, 2022.
104 Cover Page Interactive Data File (Embedded within the Inline XBRL
Document).
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses
ALLENA PHARMACEUTICALS, INC. 
